Shares of Pacific Biosciences surged another 9% in Thursday’s pre-market trading after the gene sequencing company announced a $900 million investment from SB …
In a research report issued today, William Blair analyst Amanda Murphy reiterated a Market Perform rating on Pacific Biosciences (NASDAQ:PACB). No price target …
In a research report issued today, William Blair analyst Amanda Murphy maintained a Market Perform rating on Pacific Biosciences (NASDAQ:PACB), ahead of the company’s …
After the markets closed on Thursday, July 24, Pacific Biosciences (PACB) reported second-quarter results that were in line with expectations, though the company’s …
